[New technologies of neurometabolic therapy of cerebrovascular diseases].
A purpose of the present research was the development of new treatment technologies for patients with cerebrovascular diseases by the complex application of medical physical factors directed to the correction of brain metabolism. An application of electrophoresis of mexidol and dimephosphon in the treatment of 80 patients with cerebrovascular diseases is substantiated. The clinical dynamics and effect of electrophoresis of mexidol and dimephosphon as a monotherapy as well as in combination with variable magnetic field and darsonvalization on mechanisms of electrophysiological processes, ways of formation of cerebral hemodynamic effects and adaptation in the functional systems of homeostasis and microcirculation and on the pathophysiological cascade of brain metabolism in single/serial applications were studied.
Penionzhkevich
D Iu
DIu
Gorbunov
F E
FE
D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000008:administration & dosage; D002560:Cerebrovascular Circulation / Q000502:physiology; D002561:Cerebrovascular Disorders / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D004586:Electrophoresis / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009943:Organophosphorus Compounds / Q000008:administration & dosage*; D010847:Picolines / Q000008:administration & dosage*; D050781:Transcranial Magnetic Stimulation / Q000379:methods*; D016896:Treatment Outcome
D000975:Antioxidants; D009943:Organophosphorus Compounds; D010847:Picolines; C049638:dimephosphon; C070020:emoxypine succinate